The Best Scar Removal Cream for C-Section is Scar Protocol. SEATTLE, WA / ACCESS Newswire / December 19, 2025 / With nearly 1.2 million cesarean deliveries performed annually in the United States ...
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing ...
STOCKHOLM, SE / ACCESS Newswire / December 19, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs) ...
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has ...
The "Rare Diseases Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The rare diseases treatment market is entering a pivotal phase marked by ...
As Chief Executive Officer of Alexso, Inc., a nationwide pharmaceutical distributor, Farahmand has earned recognition for pairing strategic leadership with compassion at every level of the ...
VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that Dr. Peter Singer, a global ...
The "Forklift Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The forklift market is undergoing rapid transformation, shaped by technology, ...
MURFREESBORO, TN / ACCESS Newswire / December 18, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it has invested $89.2 million, including transaction costs, in four separate ...
Following President Trump's Executive Order, MMJ International Holdings Confirms It Has Final Dose Form, Validated, Reproducible Pharmaceutical Cannabinoid Soft-Gel Capsules Ready for FDA Clinical ...
The "Orphan Drugs Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.Senior leaders in the life sciences face significant transformation in the orphan drugs ...
Neuraworx Medical Technology, Inc., a neurotechnology company developing first-in-class bioelectronic solutions for brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results